Get started
Author

Cassandra Hamilton

Observed name: Hamilton, Cassandra
ORCID: 0000-0002-0025-4081
Observed ORCID: 0000-0002-0025-4081
OpenAlex ID: A5023593650
Simultaneous selection of nanobodies for accessible epitopes on immune cells in the tumor microenvironment
2023 · Thillai V. Sekar, Eslam A. Elghonaimy, et al. · Nature Communications · 8
PDF
Immune Stromal Components Impede Biological Effectiveness of Carbon Ion Therapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
2025 · Katy L. Swancutt, Eslam A. Elghonaimy, et al. · Molecular Cancer Therapeutics · 4
Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al. · Clinical Cancer Research · 2
PDF
Soul Recovery: A Spirit Directive to Let Go
2026 · Cassandra Hamilton · Etuaptmumk The Journal of Two-Eyed Seeing
PDF
Supplementary Figure 1 from Immune Stromal Components Impede Biological Effectiveness of Carbon Ion Therapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
2026 · Katy L. Swancutt, Eslam A. Elghonaimy, et al.
Supplementary Table 1 from Immune Stromal Components Impede Biological Effectiveness of Carbon Ion Therapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
2026 · Katy L. Swancutt, Eslam A. Elghonaimy, et al.
Supplementary Raw Data from Immune Stromal Components Impede Biological Effectiveness of Carbon Ion Therapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
2026 · Katy L. Swancutt, Eslam A. Elghonaimy, et al.
Supplementary Figure 2 from Immune Stromal Components Impede Biological Effectiveness of Carbon Ion Therapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
2026 · Katy L. Swancutt, Eslam A. Elghonaimy, et al.
Data from Immune Stromal Components Impede Biological Effectiveness of Carbon Ion Therapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
2026 · Katy L. Swancutt, Eslam A. Elghonaimy, et al.
Supplementary Figure 3 from Immune Stromal Components Impede Biological Effectiveness of Carbon Ion Therapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
2026 · Katy L. Swancutt, Eslam A. Elghonaimy, et al.
Supplemental Figure 1 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Table 3 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Figure 5 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
Supplemental Figure 11 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Table 10 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Figure 4 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Table 8 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Table 4 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Figure 12 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Figure 2 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Figure 3 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Figure 10 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Figure 8 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Figure 9 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Supplemental Figure 7 from Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer
2025 · Peter Q. Leung, Eslam A. Elghonaimy, et al.
PDF
Works count: 36
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type